Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sartorius Ag (SRT3.D.DX)

Sartorius Ag (SRT3.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sartorius Ag Otto-Brenner-Strasse 20 Gottingen NI 37079 DEU

P: +49 5513080

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.

Key Statistics

Overview:

Market Capitalization, $K 13,594,372
Shares Outstanding, K 69,052
% of Institutional Shareholders 19.40%

Financials:

Annual Sales, $ 3,538 M
Annual Net Income, $ 154,900 K
Last Quarter Sales, $ 927,600 K
Last Quarter Net Income, $ 93,200 K

Growth:

1-Year Return -4.33%
3-Year Return -46.72%
5-Year Return -54.25%
5-Year Revenue Growth 8.66%
5-Year Earnings Growth -6.11%
5-Year Dividend Growth 15.50%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 2.24
EPS Growth vs. Prev Qtr 114.24%
EPS Growth vs. Prev Year 0.85%
Annual Dividend & Yield (Paid) 0.74 (0.34%)
Annual Dividend & Yield (Fwd) 0.74 (0.34%)
Most Recent Dividend 0.740 on 03/27/26
Next Ex-Dividends Date 03/27/26
Dividend Payable Date 03/31/26
Dividend Payout Ratio 33.04%
Most Recent Split 4-1 on 06/13/16

SRT3.D.DX Ratios

Ratio
Price/Earnings ttm 96.96
Price/Earnings forward 38.31
Price/Earnings to Growth 0.92
Return-on-Equity % 5.66%
Return-on-Assets % 1.56%
Profit Margin % 4.38%
Debt/Equity 1.24
Price/Sales 2.10
Price/Cash Flow 8.88
Price/Book 5.54
Book Value/Share 39.20
Interest Coverage 2.93
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.